Adecoagro (NYSE:AGRO) Stock, Quote.Headers.trade-ideas

Adecoagro

Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The company operates through three segments namely Farming, Sugar, Ethanol and Energy, and Land Transformation. The Farming segment consists of planting, harvesting, and sale of grains, oilseeds and fibers, rice, and production and sale of dairy products; the Sugar, Ethanol, and Energy segment consists of cultivating sugar cane which is processed in owned sugar mills, transformed into ethanol; and the Land Transformation segment comprises identification and acquisition of underdeveloped and undermanaged farmland.

Stock market analysts

News

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

ABNB

AGRO

BMRN

DOCS

IMCR

MODG

PODD

GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday

consumers shutter2

Long Ideas

Top 5 Defensive Stocks That May Explode This Quarter

Penny Stocks

Small Cap

Intraday Update

Movers

AAGR

ALXO

ARVN

AUVI

BITF

BMEA

CDMO

CMTL

CURV

GDHG

GTES

INTS

JOUT

LPTV

LULU

MDGL

MDRX

MLGO

MNSO

MOMO

NEPT

NETI

PARA

SLDB

SOAR

TRKA

UPST

VIRC

VRME

XCUR

Shares of Comtech Telecommunications Corp. (NASDAQ: CMTL) moved lower during Friday’s session following weak quarterly earnings.

Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Adecoagro SA

AGRO CAPITAL MGMT CP by Agro Capital Management Corp

Agro Capital Management Corp

Agronomics Ltd

WIIM

Adecoagro shares are trading lower after the company reported worse-than-expected Q3 financial results.

Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) reported quarterly earnings of $0.28 per share which missed the analyst consensus estimate of $0.69 by 59.42 percent. The company reported quarterly sales of $456.70 million which missed the analyst consensus estimate of $464.66 million by 1.71 percent. This is a 17.72 percent increase over sales of $387.95 million the same period last year.

Earnings

Earnings Misses

Adecoagro Q3 2024 Adj EPS $0.28 Misses $0.69 Estimate, Sales $456.70M Miss $464.66M Estimate

ACXP

ADAP

AEMD

AFCG

AFYA

AIRJ

ALUR

ALVO

ARCO

ATEX

AYTU

BCDA

BETR

BFRI

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BNGO

BOXL

BRFS

BWEN

CAAS

CAPR

CREX

CRNT

CSAN

CSCO

CSLR

CSTE

CYBR

DADA

DGII

DMAC

DOLE

DRRX

DTCK

ECOR

EDBL

ENLT

EZPW

FORA

FPAY

FULC

GILT

GLAD

GOEV

GRYP

HIVE

HROW

HYZN

IBTA

ICAD

ICCC

INLX

INVZ

JAGX

JJSF

KBDC

KLIC

KMDA

KRMD

KULR

LMFA

LOAR

LQDA

LUCD

LVLU

MCRB

MPTI

MRSN

NTWK

NXGL

OMER

OPRX

OTRK

OWLT

OXBR

PAVM

PCYO

Earnings Scheduled For November 13, 2024

UBS analyst Matheus Enfeldt initiates coverage on Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) with a Neutral rating and announces Price Target of $12.

Initiation

UBS Initiates Coverage On Adecoagro with Neutral Rating, Announces Price Target of $12

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page.</a>
<ul>
<li>Needham cut the price target for Immunocore Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCR#NASDAQ">IMCR</a>) from $81 to $78. Needham analyst Gil Blum maintained a Buy rating. Immunocore shares fell 1.6% to close at $33.00 on Monday. <a href="https://www.benzinga.com/quote/IMCR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Baird raised the price target for Doximity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) from $41 to $45. Baird analyst Vikram Kesavabhotla maintained an Outperform rating. Doximity shares rose 0.3% to close at $39.44 on Monday. <a href="https://www.benzinga.com/quote/docs/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B of A Securities boosted GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>) price target from $200 to $300. B of A Securities analyst Andrew Obin upgraded the stock from Neutral to Buy. GE Vernova shares rose 1.9% to close at $229.93 on Monday. <a href="https://www.benzinga.com/quote/gev/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Morgan Stanley cut Adecoagro S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) price target from $14.5 to $12.5. Morgan Stanley analyst Javier Martinez downgraded the stock from Overweight to Equal-Weight. Adecoagro shares fell 0.2% to close at $11.55 on Monday. <a href="https://www.benzinga.com/quote/agro/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Bernstein slashed the price target for Airbnb, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) from $174 to $155. Bernstein analyst Richard Clarke maintained an Outperform rating. Airbnb fell 0.2% to close at $117.55 on Monday. <a href="https://www.benzinga.com/quote/abnb/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler raised Insulet Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NASDAQ">PODD</a>) price target from $230 to $285. Piper Sandler analyst Matt O&#8217;Brien maintained an Overweight rating. Insulet shares rose 0.01% to close at $233.89 on Monday. <a href="https://www.benzinga.com/quote/podd/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel cut BioMarin Pharmaceutical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRN#NASDAQ">BMRN</a>) price target from $115 to $87. Stifel analyst Paul Matteis maintained a Buy rating. BioMarin Pharmaceutical shares fell 17.7% to close at $69.86 on Monday. <a href="https://www.benzinga.com/quote/bmrn/analyst-ratings">See how other analysts view this stock.</a></li>
<li>TD Cowen cut the price target for Topgolf Callaway Brands Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MODG#NYSE">MODG</a>) from $13 to $10. TD Cowen analyst John Kernan maintained a Hold rating. Topgolf Callaway Brands shares rose 2% to close at $10.40 on Monday. <a href="https://www.benzinga.com/quote/modg/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Stifel slashed Jabil Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) price target from $135 to $130. Stifel analyst Matthew Sheerin maintained a Buy rating. Jabil shares fell 0.2% to close at $105.72 on Monday. <a href="https://www.benzinga.com/quote/jbl/analyst-ratings">See how other analysts view this stock.</a></li>
<li>B. Riley Securities raised Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) price target from $37 to $41. B. Riley Securities analyst Lucas Pipes maintained a Neutral rating. Alcoa shares rose 6.1% to close at $34.50 on Monday. <a href="https://www.benzinga.com/quote/aa/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying GEV stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="481" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/17085859/image-132-1024x481.png" alt="" class="wp-image-551787" style="width:592px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/17085859/image-132-1024x481.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/17085859/image-132-300x141.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/17085859/image-132-768x361.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/17085859/image-132.png 1322w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40896687/how-to-earn-500-a-month-from-fedex-stock-ahead-of-q1-earnings">How To Earn $500 A Month From FedEx Stock Ahead Of Q1 Earnings</a></li>
</ul>

Morgan Stanley analyst Javier Martinez downgrades Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) from Overweight to Equal-Weight and lowers the price target from $14.5 to $12.5.

Downgrades

Morgan Stanley Downgrades Adecoagro to Equal-Weight, Lowers Price Target to $12.5

B of A Securities analyst Isabella Simonato maintains Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) with a Buy and lowers the price target from $15.5 to $14.5.

B of A Securities Maintains Buy on Adecoagro, Lowers Price Target to $14.5

Adecoagro shares are trading higher after the company reported a year-over-year increase in Q2 EPS results and reported better-than-expected Q2 sales results.

Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) reported quarterly earnings of $1.03 per share. This is a 157.5 percent increase over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $397.55 million which beat the analyst consensus estimate of $379.00 million by 4.89 percent. This is a 2.34 percent decrease over sales of $407.08 million the same period last year.

Earnings Beats

Adecoagro Q2 EPS $1.03 Up From $0.40 YoY, Sales $397.55M Beat $379.00M Estimate

JP Morgan analyst Lucas Ferreira upgrades Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) from Underweight to Neutral and raises the price target from $10.5 to $11.5.

Upgrades

JP Morgan Upgrades Adecoagro to Neutral, Raises Price Target to $11.5

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>)</h3>
<ul>
<li>On May 22, Molson Coors Beverage Company announced the pricing of its public offering of euro-denominated senior notes. The company's stock fell around 7% over the past month and has a <a href="https://www.benzinga.com/quote/TAP">52-week low of $52.60</a>.</li>
<li>RSI Value: 23.78</li>
<li>TAP Price Action: Shares of Molson Coors Beverage gained 0.4% to close at $53.22 on Thursday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://pro.benzinga.com/dashboard">latest TAP news</a>.</li>
</ul>
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="560" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041808/Screenshot-2024-05-31-at-1.47.59-PM-1024x560.png" alt="" class="wp-image-364744" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041808/Screenshot-2024-05-31-at-1.47.59-PM-1024x560.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041808/Screenshot-2024-05-31-at-1.47.59-PM-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041808/Screenshot-2024-05-31-at-1.47.59-PM-768x420.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041808/Screenshot-2024-05-31-at-1.47.59-PM.png 1369w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<h3 class="wp-block-heading">Adecoagro S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>)&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On May 16, Adecoagro posted better-than-expected quarterly sales. The company's stock fell around 10% over the past month. It <a href="ttps://www.benzinga.com/quote/AGRO">has a 52-week low</a> of $8.82.</li>
<li>RSI Value: 29.47</li>
<li>AGRO Price Action: Shares of Adecoagro gained 0.8% to close at $9.78 on Thursday.</li>
<li><a href="https://pro.benzinga.com/dashboard">Benzinga Pro's charting tool</a> helped identify the trend in Adecoagro's stock.</li>
</ul>
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="536" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041948/Screenshot-2024-05-31-at-1.49.40-PM-1024x536.png" alt="" class="wp-image-364748" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041948/Screenshot-2024-05-31-at-1.49.40-PM-1024x536.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041948/Screenshot-2024-05-31-at-1.49.40-PM-300x157.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041948/Screenshot-2024-05-31-at-1.49.40-PM-768x402.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31041948/Screenshot-2024-05-31-at-1.49.40-PM.png 1380w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<h3 class="wp-block-heading">The Kroger Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>)</h3>
<ul>
<li>On May 15, GoodRx Holdings announced a new direct contracting agreement with Kroger. The company's stock fell around 3% over the past five days and has a 52-week l<a href="https://www.benzinga.com/quote/KR">ow of $42.10.</a></li>
<li>RSI Value: 29.17</li>
<li>KR Price Action: Shares of Kroger rose 0.2% to close at $51.98 on Thursday.</li>
<li>Benzinga Pro's earnings calendar was used to track <a href="https://pro.benzinga.com/dashboard">Kroger's upcoming earnings report</a></li>
</ul>
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="561" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042054/Screenshot-2024-05-31-at-1.50.47-PM-1024x561.png" alt="" class="wp-image-364749" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042054/Screenshot-2024-05-31-at-1.50.47-PM-1024x561.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042054/Screenshot-2024-05-31-at-1.50.47-PM-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042054/Screenshot-2024-05-31-at-1.50.47-PM-768x421.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042054/Screenshot-2024-05-31-at-1.50.47-PM.png 1378w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<h3 class="wp-block-heading">The Boston Beer Company, Inc.. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAM#NYSE">SAM</a>)</h3>
<ul>
<li>On April 25, Boston Beer reported better-than-expected first-quarter financial results and issued FY24 GAAP EPS guidance. &#8220;We were pleased to see flat depletion trends in the first quarter and to deliver revenue growth,&#8221; said Chairman and Founder Jim Koch. &#8220;We remain committed to investing across our portfolio of brands to drive long-term revenue growth while also expanding our margins.&#8221; The company's shares lost around 8% over the past month. The company's 52-week low is $254.40.</li>
<li>RSI Value: 29.37</li>
<li>SAM Price Action: Shares of Boston Beer rose 0.2% to close at $256.41 on Thursday.</li>
<li><a href="https://pro.benzinga.com/dashboard">Benzinga Pro's signals feature</a> notified of a potential breakout in Boston Beer shares.</li>
</ul>
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="577" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042205/Screenshot-2024-05-31-at-1.51.55-PM-1024x577.png" alt="" class="wp-image-364751" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042205/Screenshot-2024-05-31-at-1.51.55-PM-1024x577.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042205/Screenshot-2024-05-31-at-1.51.55-PM-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042205/Screenshot-2024-05-31-at-1.51.55-PM-768x433.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042205/Screenshot-2024-05-31-at-1.51.55-PM.png 1370w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
<h3 class="wp-block-heading">Hormel Foods Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRL#NYSE">HRL</a>)</h3>
<ul>
<li>On May 30, Hormel Foods reported second-quarter fiscal 2024 sales declined 3% year-over-year to $2.887 billion, missing the consensus of $2.967 billion. "To reflect our solid first-half performance and our expectations for continued growth from our Foodservice and International segments, ongoing improvements across our supply chain, and further benefits from our transform and modernize initiative, we are updating our full-year earnings outlook," stated Jim Snee, chairman of the board, president and chief executive officer. The company's shares fell around 13% over the past five days. The company <a href="https://www.benzinga.com/quote/HRL">has a 52-week low</a> of $28.51.</li>
<li>RSI Value: 22.95</li>
<li>HRL Price Action: Shares of Hormel Foods fell 9.7% to close at $30.79 on Thursday.</li>
<li><a href="https://pro.benzinga.com/dashboard">Insider trades for Hormel Foods</a> were monitored using Benzinga Pro.</li>
</ul>
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="566" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042332/Screenshot-2024-05-31-at-1.53.25-PM-1024x566.png" alt="" class="wp-image-364752" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042332/Screenshot-2024-05-31-at-1.53.25-PM-1024x566.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042332/Screenshot-2024-05-31-at-1.53.25-PM-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042332/Screenshot-2024-05-31-at-1.53.25-PM-768x424.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/05/31042332/Screenshot-2024-05-31-at-1.53.25-PM.png 1378w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read More: <a href="https://www.benzinga.com/news/earnings/24/05/39104172/dell-asana-and-3-stocks-to-watch-heading-into-friday">Dell, Asana And 3 Stocks To Watch Heading Into Friday</a>

Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) reported quarterly earnings of $0.22 per share. The company reported quarterly sales of $253.799 million which beat the analyst consensus estimate of $245.000 million by 3.59 percent. This is a 3.50 percent increase over sales of $245.213 million the same period last year.

Adecoagro Q1 2024 GAAP EPS $0.22, Sales $253.799M Beat $245.000M Estimate

Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) reported quarterly losses of $(0.15) per share. This is a 188.24 percent decrease over earnings of $0.17 per share from the same period last year. The company reported $400.14 million in sales this quarter. This is a 7.21 percent increase over sales of $373.24 million the same period last year.

Adecoagro Q4 EPS $(0.15) Down From $0.17 YoY, Sales $400.14M Up From $373.24M YoY

Adecoagro 2023 Adj. EBITDA $476.6M, Up 10.1% YoY

<h3>Companies Reporting Before The Bell</h3>
&bull; Pharming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHAR#NASDAQ">PHAR</a>) is projected to report earnings for its fourth quarter.
&bull; ImmunoPrecise Antibodies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPA#NASDAQ">IPA</a>) is likely to report quarterly loss at $0.07 per share on revenue of $4.50 million.
&bull; G-III Apparel Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIII#NASDAQ">GIII</a>) is projected to report quarterly earnings at $0.67 per share on revenue of $817.48 million.
&bull; Dick&#39;s Sporting Goods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DKS#NYSE">DKS</a>) is estimated to report quarterly earnings at $3.35 per share on revenue of $3.80 billion.
&bull; Protalix BioTherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PLX#AMEX">PLX</a>) is likely to report quarterly loss at $0.03 per share on revenue of $5.80 million.
&bull; Hello Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOMO#NASDAQ">MOMO</a>) is likely to report quarterly earnings at $0.34 per share on revenue of $405.61 million.
&bull; Weibo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WB#NASDAQ">WB</a>) is expected to report quarterly earnings at $0.49 per share on revenue of $455.09 million.
&bull; Futu Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>) is projected to report quarterly earnings at $0.96 per share on revenue of $331.79 million.
&bull; Akebia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKBA#NASDAQ">AKBA</a>) is expected to report quarterly loss at $0.04 per share on revenue of $55.39 million.
&bull; Kandi Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNDI#NASDAQ">KNDI</a>) is projected to report earnings for its fourth quarter.
&bull; Benson Hill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHIL#NYSE">BHIL</a>) is estimated to report quarterly loss at $0.17 per share on revenue of $87.30 million.
&bull; KE Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEKE#NYSE">BEKE</a>) is likely to report quarterly earnings at $0.18 per share on revenue of $2.63 billion.
&bull; Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) is expected to report quarterly earnings at $1.75 per share on revenue of $9.78 billion.
&bull; Hudson Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSON#NASDAQ">HSON</a>) is estimated to report quarterly earnings at $0.20 per share on revenue of $38.02 million.
&bull; InfuSystems Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INFU#AMEX">INFU</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $30.00 million.
&bull; HF Foods Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HFFG#NASDAQ">HFFG</a>) is likely to report earnings for its fourth quarter.
&bull; Burford Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BUR#NYSE">BUR</a>) is estimated to report earnings for its Fiscal Year 2023.
&bull; Ucloudlink Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCL#NASDAQ">UCL</a>) is expected to report quarterly earnings at $0.05 per share on revenue of $23.60 million.
&bull; Xunlei (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XNET#NASDAQ">XNET</a>) is likely to report earnings for its fourth quarter.
&bull; Build-A-Bear Workshop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBW#NYSE">BBW</a>) is projected to report quarterly earnings at $1.32 per share on revenue of $150.45 million.
&bull; Global X Guru Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GURU#NYSE">GURU</a>) is projected to report quarterly loss at $0.05 per share on revenue of $6.85 million.
&bull; Century Casinos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTY#NASDAQ">CNTY</a>) is expected to report quarterly loss at $0.36 per share on revenue of $142.31 million.
&bull; Katapult Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KPLT#NASDAQ">KPLT</a>) is expected to report quarterly loss at $1.79 per share on revenue of $55.81 million.
&bull; UroGen Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>) is estimated to report quarterly loss at $0.68 per share on revenue of $22.57 million.
&bull; Agenus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGEN#NASDAQ">AGEN</a>) is projected to report quarterly loss at $0.05 per share on revenue of $47.05 million.
&bull; RumbleON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) is estimated to report quarterly loss at $0.51 per share on revenue of $339.48 million.
&bull; Alarum Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAR#NASDAQ">ALAR</a>) is expected to report quarterly earnings at $0.25 per share on revenue of $7.00 million.
&bull; Autolus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUTL#NASDAQ">AUTL</a>) is estimated to report quarterly loss at $0.25 per share on revenue of $360 thousand.
&bull; United Homes Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UHG#NASDAQ">UHG</a>) is projected to report earnings for its first quarter.
&bull; BK Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BKTI#AMEX">BKTI</a>) is likely to report earnings for its fourth quarter.
&bull; Solo Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTC#NYSE">DTC</a>) is expected to report quarterly earnings at $0.17 per share on revenue of $166.15 million.
&bull; Mondee Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOND#NASDAQ">MOND</a>) is likely to report quarterly loss at $0.12 per share on revenue of $55.00 million.
&bull; GoHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOCO#NASDAQ">GOCO</a>) is likely to report quarterly earnings at $2.72 per share on revenue of $363.88 million.
&bull; SecureWorks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWX#NASDAQ">SCWX</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $87.18 million.
&bull; Aveanna Healthcare Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAH#NASDAQ">AVAH</a>) is projected to report quarterly loss at $0.02 per share on revenue of $467.40 million.
&bull; PSQ Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSQH#NYSE">PSQH</a>) is expected to report quarterly loss at $0.47 per share on revenue of $2.47 million.
&bull; Canadian Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $1.69 billion.
&bull; CION Invt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CION#NYSE">CION</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $58.33 million.
<h3>Companies Reporting After The Bell</h3>
&bull; Blend Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) is expected to report quarterly loss at $0.09 per share on revenue of $36.93 million.
&bull; Montauk Renewables (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNTK#NASDAQ">MNTK</a>) is estimated to report quarterly earnings at $0.07 per share on revenue of $56.87 million.
&bull; Getty Images Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GETY#NYSE">GETY</a>) is estimated to report quarterly earnings at $0.01 per share on revenue of $216.46 million.
&bull; Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) is likely to report quarterly earnings at $7.53 per share on revenue of $3.53 billion.
&bull; Skillz (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKLZ#NYSE">SKLZ</a>) is projected to report quarterly loss at $1.41 per share on revenue of $38.09 million.
&bull; Rigetti Computing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) is expected to report quarterly loss at $0.13 per share on revenue of $3.22 million.
&bull; Smartsheet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMAR#NYSE">SMAR</a>) is estimated to report quarterly earnings at $0.18 per share on revenue of $255.38 million.
&bull; Phreesia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHR#NYSE">PHR</a>) is expected to report quarterly loss at $0.26 per share on revenue of $93.53 million.
&bull; Despegar.com (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DESP#NYSE">DESP</a>) is projected to report quarterly earnings at $0.17 per share on revenue of $191.43 million.
&bull; Frequency Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEIM#NASDAQ">FEIM</a>) is projected to report earnings for its third quarter.
&bull; Pyxis Tankers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXS#NASDAQ">PXS</a>) is projected to report earnings for its fourth quarter.
&bull; American Vanguard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVD#NYSE">AVD</a>) is likely to report quarterly earnings at $0.27 per share on revenue of $172.90 million.
&bull; The One Group Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKS#NASDAQ">STKS</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $98.04 million.
&bull; Urgently (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULY#NASDAQ">ULY</a>) is likely to report earnings for its fourth quarter.
&bull; Vaxart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VXRT#NASDAQ">VXRT</a>) is likely to report quarterly loss at $0.14 per share on revenue of $1.25 million.
&bull; Evoke Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVOK#NASDAQ">EVOK</a>) is likely to report quarterly loss at $0.50 per share on revenue of $1.63 million.
&bull; Marchex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHX#NASDAQ">MCHX</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $12.75 million.
&bull; Kopin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>) is projected to report quarterly loss at $0.02 per share on revenue of $9.03 million.
&bull; Eastman Kodak (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KODK#NYSE">KODK</a>) is projected to report earnings for its fourth quarter.
&bull; Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) is projected to report quarterly earnings at $0.26 per share on revenue of $275.87 million.
&bull; Tilly&#39;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) is projected to report quarterly loss at $0.22 per share on revenue of $171.65 million.
&bull; CytoSorbents (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTSO#NASDAQ">CTSO</a>) is projected to report quarterly loss at $0.14 per share on revenue of $9.28 million.
&bull; Energy Transfer (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>) is projected to report quarterly earnings at $0.22 per share on revenue of $125.84 million.
&bull; Allogene Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLO#NASDAQ">ALLO</a>) is projected to report quarterly loss at $0.45 per share on revenue of $20 thousand.
&bull; Adecoagro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>) is expected to report earnings for its fourth quarter.
&bull; Redwire (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDW#NYSE">RDW</a>) is expected to report quarterly loss at $0.12 per share on revenue of $59.72 million.
&bull; Fathom Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTHM#NASDAQ">FTHM</a>) is estimated to report quarterly loss at $0.32 per share on revenue of $80.97 million.
&bull; Brilliant Earth Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRLT#NASDAQ">BRLT</a>) is estimated to report quarterly earnings at $0.01 per share on revenue of $124.61 million.
&bull; Karat Packaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRT#NASDAQ">KRT</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $95.48 million.
&bull; Mobile Infrastructure (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BEEP#AMEX">BEEP</a>) is estimated to report earnings for its fourth quarter.
&bull; Babcock &amp; Wilcox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BW#NYSE">BW</a>) is likely to report quarterly loss at $0.03 per share on revenue of $256.27 million.
&bull; Cardlytics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDLX#NASDAQ">CDLX</a>) is projected to report quarterly earnings at $0.12 per share on revenue of $89.55 million.
&bull; Eton Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETON#NASDAQ">ETON</a>) is expected to report quarterly loss at $0.04 per share on revenue of $7.70 million.
&bull; EverCommerce (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVCM#NASDAQ">EVCM</a>) is expected to report quarterly earnings at $0.13 per share on revenue of $172.41 million.
&bull; Co-Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODX#NASDAQ">CODX</a>) is expected to report quarterly loss at $0.20 per share on revenue of $3.62 million.
&bull; Acacia Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACTG#NASDAQ">ACTG</a>) is likely to report quarterly earnings at $0.07 per share on revenue of $8.00 million.
&bull; Alta Equipment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTG#NYSE">ALTG</a>) is estimated to report quarterly loss at $0.05 per share on revenue of $483.69 million.
&bull; Wheaton Precious Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPM#NYSE">WPM</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $291.55 million.
&bull; Spruce Power Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPRU#NYSE">SPRU</a>) is likely to report earnings for its fourth quarter.
&bull; aTyr Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIFE#NASDAQ">LIFE</a>) is estimated to report quarterly loss at $0.24 per share on revenue of $50 thousand.
&bull; Clipper Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLPR#NYSE">CLPR</a>) is projected to report earnings for its fourth quarter.
&bull; Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) is likely to report quarterly earnings at $4.38 per share on revenue of $5.14 billion.
&bull; Heritage Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HGBL#NASDAQ">HGBL</a>) is expected to report quarterly earnings at $0.07 per share on revenue of $15.35 million.
&bull; NuScale Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) is projected to report quarterly loss at $0.14 per share on revenue of $8.94 million.
&bull; Altus Power (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPS#NYSE">AMPS</a>) is expected to report quarterly loss at $0.01 per share on revenue of $43.93 million.
&bull; Molecular Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOLN#NASDAQ">MOLN</a>) is likely to report earnings for its Fiscal Year 2023.
&bull; FutureFuel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FF#NYSE">FF</a>) is likely to report earnings for its fourth quarter.
&bull; Harte-Hanks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HHS#NASDAQ">HHS</a>) is expected to report quarterly earnings at $0.12 per share on revenue of $47.00 million.
&bull; Blink Charging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) is likely to report quarterly loss at $0.31 per share on revenue of $35.64 million.
&bull; PagerDuty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PD#NYSE">PD</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $110.40 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

Comments

Adecoagro

Adecoagro (AGRO) Forecast

Adecoagro (NYSE:AGRO) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga